Skip to main content

Table 1 SMAD4 expression in human glioma tissues with different clinical-pathological features

From: Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients

Clinicopathological features

No. of cases

SMAD4 (n)

P

  

-

+

++

+++

 

WHO grade

 

114

60

51

27

 

I

53

12

16

13

12

0.008

II

60

17

21

15

7

 

III

62

34

12

11

5

 

IV

77

51

11

12

3

 

Age

      

<55

152

65

39

31

17

NS

≥55

100

49

21

20

10

 

Gender

      

Male

138

57

36

30

15

NS

Female

114

57

24

21

12

 

KPS

      

<80

135

81

25

21

8

<0.001

≥80

117

33

35

30

19

Â